Word: myeloma
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
DIED. Louis Rukeyser, 73, trailblazing stock market broadcaster whose lively analysis and open disdain for professional investors made Wall Street Week, the low-tech TV program he hosted for 32 years, one of PBS's best-rated shows; of multiple myeloma, a rare bone cancer; in Greenwich, Conn. With his tailored suits and wry delivery, Rukeyser became an unlikely celebrity from the world of economics, and PEOPLE magazine called him "the dismal science's only sex symbol." After PBS replaced him on the show in 2002, he hosted a CNBC program until failing health forced him to retire...
...expecting a decision from the FDA on its colon-cancer drug, Avastin, which targets one of the growth factors released by the body as inflammation gives way to healing. Millennium Pharmaceuticals is testing a different kind of drug, called Velcade, which has already been approved for treating multiple myeloma, against lung cancer and other malignancies. But there is a sense that much more basic research into the nature of inflammation needs to be done before scientists understand how best to limit the damage in chronic diseases...
...research groups are exploring how thalidomide can be used to stop blood vessels forming in and around tumors. Kill the formation of new vessels, they reason, and you kill the tumor. Recent studies into thalidomide treatment of some of the most intractable cancers - lung and pancreatic cancer and multiple myeloma - show promising results. Thalidomide has "three exciting properties to home in on: it can inhibit tumors directly, activate the immune system and be anti-inflammatory," says Keith Dredge of St. George's Hospital Medical School in London, who's working with Revamid, a type of thalidomide, in patients with melanoma...
DIED. J. CARTER BROWN, 67, patrician populist who, as head of Washington's National Gallery of Art, helped transform America's museums from dusty vaults to extravagant showplaces for the masses; of multiple myeloma; in Boston. During his 23-year tenure, Brown boosted federal funding for the gallery and repositioned it as a rival of New York City's Metropolitan Museum of Art. He pioneered the phenomenon of the blockbuster exhibition with such shows as King Tut and Andrew Wyeth's "Helga" series...
...Cambridge, Mass., Millennium Pharmaceuticals is focusing on proteins called proteasomes, which evidently play a role in giving cancer cells unnaturally long lives. The company is in Phase II trials with LDP341, a proteasome-inhibiting substance that is showing promise against multiple myeloma and chronic lymphocytic leukemia. Phase I studies on the top five solid tumors (breast, pancreatic, prostate, lung and colon) are under way, and at this point the inhibitor seems to be working--at least in mice...